Literature DB >> 27511902

Predictive global trends in the incidence and mortality of pancreatic cancer based on geographic location, socio-economic status, and demographic shift.

Chandrakanth Are1, Sanjib Chowdhury2, Humera Ahmad3, Advaitaa Ravipati4, Tianqiang Song5, Shailesh Shrikandhe6, Lynette Smith7.   

Abstract

BACKGROUND AND OBJECTIVES: Pancreatic Cancer (PC) is a lethal malignancy that accounts for about 4% of cancer-related deaths worldwide. The aim of this study is to describe the influence of geography (based on WHO regions), socio-economic development (based on Human Development Index [HDI]) and demographic shift on the temporal trends in global incidence and mortality of PC.
METHODS: Data (2012-2030) relating to the incidence, mortality of PC and demographic shifts based on WHO regions and HDI areas were extracted from GLOBOCAN 2012. Linear regression was used to evaluate trends in total incidence and mortality.
RESULTS: We noted a definite association between PC and higher socio-economic status. Advanced age (age ≥65) contributed to the rising burden in all socio-economic regions of the world except in the Low Human Development (LHD) countries where the disease predominantly affected population <65 years of age.
CONCLUSIONS: The global burden of PC is expected to rise significantly over the next few decades regardless of geographic location, socio-economic development, age and gender. Advance knowledge of this data can help formulate strategies to specifically target countries and populations that promote public health policy to tackle this lethal disease on the global stage. J. Surg. Oncol. 2016;114:736-742.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Human Development Index (HDI); WHO regions; demographic shift; global pancreatic cancer burden; predictive trends based on GLOBOCAN 2012 database

Mesh:

Year:  2016        PMID: 27511902     DOI: 10.1002/jso.24410

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma.

Authors:  Eric M Wang; Hironari Akasaka; Jun Zhao; Gauri R Varadhachary; Jeffrey E Lee; Anirban Maitra; Jason B Fleming; Mien-Chie Hung; Huamin Wang; Matthew H G Katz
Journal:  Pancreas       Date:  2019-03       Impact factor: 3.327

Review 2.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

3.  Focus on an unusual rise in pancreatic cancer incidence in France.

Authors:  Anne-Marie Bouvier; Zoé Uhry; Valérie Jooste; Antoine Drouillard; Laurent Remontet; Guy Launoy; Nathalie Leone
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

Review 4.  Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC).

Authors:  Hani M Babiker; Michael Karass; Alejandro Recio-Boiles; Sreenivasa R Chandana; Ali McBride; Daruka Mahadevan
Journal:  Expert Opin Investig Drugs       Date:  2019-06-21       Impact factor: 6.206

5.  Thyroid Cancer: Global Burden and Trends.

Authors:  Jessica B Shank; Chandrakanth Are; Chelsea D Wenos
Journal:  Indian J Surg Oncol       Date:  2021-09-04

6.  Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects.

Authors:  Byung Kyu Park; Jeong Hun Seo; Jae Bock Chung; Jung Kyu Choi
Journal:  Br J Cancer       Date:  2022-04-20       Impact factor: 9.075

7.  Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.

Authors:  Deyali Chatterjee; Matthew H Katz; Wai Chin Foo; Manonmani Sundar; Hua Wang; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Anirban Maitra; Jason B Fleming; Asif Rashid; Huamin Wang
Journal:  Am J Surg Pathol       Date:  2017-08       Impact factor: 6.298

Review 8.  Update on quantitative radiomics of pancreatic tumors.

Authors:  Mayur Virarkar; Vincenzo K Wong; Ajaykumar C Morani; Eric P Tamm; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2021-07-22

9.  Assessing the Relationship between Chronic Lymphoid Leukemia Mortality Rates and Human Development Index: A 26-Year Trend Analysis Using Location-Scale Mixed Effects Model.

Authors:  Parisa Rezanejad Asl; Farid Zayeri; Alireza Moghisi
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

10.  Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.

Authors:  Yinlei Dong; Junjie Tian; Bingqian Yan; Kun Lv; Ji Li; Deliang Fu
Journal:  Pathol Oncol Res       Date:  2021-07-05       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.